Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384442 | SCV001583940 | pathogenic | not provided | 2022-11-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 162401). This premature translational stop signal has been observed in individuals with Seckel syndrome (PMID: 25320347, 25344692). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs724159996, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Phe433Leufs*6) in the PLK4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PLK4 are known to be pathogenic (PMID: 25320347, 30842647). |
Gene |
RCV001384442 | SCV003930558 | uncertain significance | not provided | 2022-11-30 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; This variant is associated with the following publications: (PMID: 25320347, 25344692, 32552793, 30214071, 33756487) |
Center for Genomic Medicine, |
RCV000149796 | SCV005374029 | pathogenic | Microcephaly and chorioretinopathy 2 | 2024-09-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000149796 | SCV000196605 | pathogenic | Microcephaly and chorioretinopathy 2 | 2014-12-01 | no assertion criteria provided | literature only | |
Service de Génétique Moléculaire, |
RCV000149796 | SCV001432382 | pathogenic | Microcephaly and chorioretinopathy 2 | no assertion criteria provided | clinical testing | ||
Clinical Laboratory Sciences Program |
RCV000149796 | SCV003927808 | pathogenic | Microcephaly and chorioretinopathy 2 | 2023-04-01 | no assertion criteria provided | clinical testing |